The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1544, doi. 10.1007/s11095-017-2128-0
- By:
- Publication type:
- Article
Works matching IS 07248741 AND DT 2017 AND VI 34 AND IP 8
Results: 21
1
2
Network Reconstruction Reveals that Valproic Acid Activates Neurogenic Transcriptional Programs in Adult Brain Following Traumatic Injury.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1658, doi. 10.1007/s11095-017-2130-6
- By:
- Publication type:
- Article
3
Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1556, doi. 10.1007/s11095-017-2150-2
- By:
- Publication type:
- Article
4
Transmembrane Domain Single-Nucleotide Polymorphisms Impair Expression and Transport Activity of ABC Transporter ABCG2.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1626, doi. 10.1007/s11095-017-2127-1
- By:
- Publication type:
- Article
5
Virtual Clinical Studies to Examine the Probability Distribution of the AUC at Target Tissues Using Physiologically-Based Pharmacokinetic Modeling: Application to Analyses of the Effect of Genetic Polymorphism of Enzymes and Transporters on Irinotecan Induced Side Effects
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1584, doi. 10.1007/s11095-017-2153-z
- By:
- Publication type:
- Article
6
Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury?
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1564, doi. 10.1007/s11095-016-2091-1
- By:
- Publication type:
- Article
7
Regulatory Variants Modulate Protein Kinase C α ( PRKCA) Gene Expression in Human Heart.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1648, doi. 10.1007/s11095-017-2102-x
- By:
- Publication type:
- Article
8
CYP2D6 Genetic Variation and Beta-Blocker Maintenance Dose in Patients with Heart Failure.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1615, doi. 10.1007/s11095-017-2104-8
- By:
- Publication type:
- Article
9
RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1673, doi. 10.1007/s11095-017-2154-y
- By:
- Publication type:
- Article
10
In Vitro Transport Activity and Trafficking of MRP2/ ABCC2 Polymorphic Variants.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1637, doi. 10.1007/s11095-017-2160-0
- By:
- Publication type:
- Article
11
Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1551, doi. 10.1007/s11095-017-2163-x
- By:
- Publication type:
- Article
12
A Functional Iron Oxide Nanoparticles Modified with PLA-PEG-DG as Tumor-Targeted MRI Contrast Agent.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1683, doi. 10.1007/s11095-017-2165-8
- By:
- Publication type:
- Article
13
A Clinical Cassette Dosing Study for Evaluating the Contribution of Hepatic OATPs and CYP3A to Drug-Drug Interactions.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1570, doi. 10.1007/s11095-017-2168-5
- By:
- Publication type:
- Article
14
Personalized Therapeutics and Pharmacogenomics: Integral to Personalized Health Care.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
15
Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1693, doi. 10.1007/s11095-017-2177-4
- By:
- Publication type:
- Article
16
Effect of Relative Humidity on Bipolar Electrostatic Charge Profiles of dry Powder Aerosols.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1707, doi. 10.1007/s11095-017-2178-3
- By:
- Publication type:
- Article
17
Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4 T-Cell Responses.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1716, doi. 10.1007/s11095-017-2180-9
- By:
- Publication type:
- Article
18
Selection of P-Glycoprotein Inhibitor and Formulation of Combinational Nanoformulation Containing Selected Agent Curcumin and DOX for Reversal of Resistance in K562 Cells.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1741, doi. 10.1007/s11095-017-2182-7
- By:
- Publication type:
- Article
19
Investigation of Glycochenodeoxycholate Sulfate and Chenodeoxycholate Glucuronide as Surrogate Endogenous Probes for Drug Interaction Studies of OATP1B1 and OATP1B3 in Healthy Japanese Volunteers.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1601, doi. 10.1007/s11095-017-2184-5
- By:
- Publication type:
- Article
20
Personalized Drug Dosage - Closing the Loop.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1539, doi. 10.1007/s11095-016-2076-0
- By:
- Publication type:
- Article
21
Developing Transdermal Applications of Ketorolac Tromethamine Entrapped in Stimuli Sensitive Block Copolymer Hydrogels.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1728, doi. 10.1007/s11095-017-2181-8
- By:
- Publication type:
- Article